92 related articles for article (PubMed ID: 19782923)
1. Correlation between the prevalence of type 1 diabetes with the daily insulin dose and the autoimmune process against glutamic acid decarboxylase in adults.
Khalangot M; Kravchenko V; Tronko M; Gur'ianov V
Eur J Intern Med; 2009 Oct; 20(6):611-5. PubMed ID: 19782923
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
3. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
[TBL] [Abstract][Full Text] [Related]
5. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
[TBL] [Abstract][Full Text] [Related]
7. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
[TBL] [Abstract][Full Text] [Related]
9. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
12. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
Ota T; Takamura T; Nagai Y; Bando Y; Usuda R
Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
[TBL] [Abstract][Full Text] [Related]
13. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
14. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
Monge L; Bruno G; Pinach S; Grassi G; Maghenzani G; Dani F; Pagano G
Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune diabetes in adults: lessons from the UKPDS.
Desai M; Clark A
Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
[TBL] [Abstract][Full Text] [Related]
16. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
18. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
[TBL] [Abstract][Full Text] [Related]
19. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
20. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
